Key Highlights
- Deb Autor, former FDA Deputy Commissioner, joins Hims & Hers Board of Directors.
- Janet Stevens, pharmaceutical quality expert, named Global Head of Quality & Safety.
- Commitment to clinical excellence, safety, and quality at scale.
- Leadership team includes industry veterans from Pfizer, AstraZeneca, and Hillrom.
Source: Business Wire
Notable Quotes
- “The depth of expertise Deb and Janet bring to the team is incredibly valuable as we continue to scale our operations to meet the needs of the growing number of customers who come to our platform seeking healthcare solutions that fit their individual needs.” — Andrew Dudum, CEO and co-founder at Hims & Hers
- “In my many decades in the healthcare field, this is the first company I’ve seen achieving scale, impact, and quality while pushing innovation in the service of patients.” — Deb Autor, Board Member at Hims & Hers
- “The safety of our operations is the foundation of connection we have with our customers. Continuing to strengthen that connection will be a critical part of impacting more lives on our platform.” — Janet Stevens, Global Head of Quality & Safety at Hims & Hers
SoHC's Take
Hims & Hers is doubling down on its commitment to safety, quality, and personalized care with the appointment of proven leaders in pharmaceutical regulation and quality assurance. The addition of Deb Autor and Janet Stevens is not only a significant milestone but also a clear signal to customers and stakeholders about the company’s dedication to setting the gold standard in accessible, safe, and innovative healthcare solutions. As the healthcare landscape continues to evolve, these strategic hires position Hims & Hers to lead the way in scaling quality healthcare while earning and maintaining consumer trust.
